Induction & Augmentation
This document is designed to support midwives in contextualizing the results of the ARRIVE trial when talking to clients and other healthcare providers.
An overview of select evidence related to key outcomes of interest to midwives caring for clients who are age 40 and older.
For Clients: In Due Time: Pregnancy Beyond 40 and Induction of Labour
A focused review of the research regarding induction of labour for clients who are age 40 and over. This client resource is also available in five other languages.
HIROC's risk reference sheet on induction and augmentation
Reviews themes from past incidents and opportunities to avoid similar incidents in the future.
Sample protocols, submitted by midwifery practices, are available on Induction and Augmentation for practices to download and adapt. Be sure to tailor the template to reflect current evidence, best practices and practice group / community specific info before use.
The Provincial Council for Maternal and Child Health (PCMCH) has developed best practice recommendations for the safe administration of oxytocin used in augmentation and/or induction.
Institute for Safe Medication Practices Canada analyzed oxytocin incidents nationally and identified themes to support systemic improvements.
This infographic summarizes key messages related to the use and management of oxytocin in labour induction and augmentation.